Researchers evaluated an electronic health record-based intervention that identified patients with metastatic cancer for a multipronged approach to their in-hospital care. An EHR-based intervention ...

In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines.

(HealthDay News) — The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications ...

(HealthDay News) — Radiation therapy can promote the epidermal growth factor receptor (EGFR) ligand amphiregulin, which increases growth of existing metastases in patients with advanced solid tumors, ...

Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes.

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Frequent cystoscopy for monitoring nonmuscle-invasive bladder cancer (NMIBC) is burdensome and costly, prompting a search for alternatives.

Investigators conducted a qualitative study of Medicare Advantage expansion and marketing to patients with end-stage kidney disease (ESKD).

The tissue damage and anatomical distortion caused by primary prostate cancer treatment are major challenges for surgeons performing salvage surgery.

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

However, incidence rates of vision-threatening diabetic retinopathy, diabetic macular edema, and proliferative diabetic retinopathy have decreased.